Mario Schröder, Max Buchinger, Iulia Dahmer, Peter Eickholz, Hari Petsos
{"title":"Clinical Treatment Endpoints After Active Periodontal Treatment and 10 Years of Supportive Periodontal Care: A Retrospective Cohort Study","authors":"Mario Schröder, Max Buchinger, Iulia Dahmer, Peter Eickholz, Hari Petsos","doi":"10.1111/jcpe.14179","DOIUrl":null,"url":null,"abstract":"ObjectivesComparing periodontal stability following active periodontal treatment (APT/T1) and 120 ± 12 months of supportive periodontal care (SPC/T2) using four clinical endpoints (CEPs).MethodsCEP1: pocket probing depths (PPD) ≤ 4 mm, no sites with ≥ 4 mm with bleeding on probing (BOP), and total BOP < 10%; CEP2: no PPD > 4 mm with BOP or PPD ≥ 6 mm; CEP3: ≤ 4 sites with PPD ≥ 5 mm; CEP4: ≤ 5 teeth with PPD ≥ 5 mm. Assuming CEPs are mutually exclusive, patient‐ and tooth‐related parameters (e.g., periodontal tooth loss: PTL) were compared. Using receiver operating characteristic analysis for the prediction of PTL as a cutoff for CEP was assessed.ResultsFrom 128 patients (age 65.5 ± 10.5 years; 83 stage III, 45 stage IV; 47 grade B, 81 grade C), 7 achieved CEP1, 23 CEP2, 45 CEP3, 23 CEP4, 30 noCEP at T1. At T2, six patients reached CEP1, 37 CEP2, 38 CEP3, 35 CEP4, 12 noCEP. For noCEP, the number of sites with PPD > 5 mm increased significantly, and PTL was higher compared to CEP1, CEP2 and CEP3 (<jats:italic>p</jats:italic> < 0.001).ConclusionsWhile achieving CEP1 is possible through comprehensive APT, treating a chronic disease often leads to less ideal CEP2/CEP3. Achieving CEP1, CEP2 or CEP3 after APT made no observable difference regarding PTL.Trial Registration: The study is registered with the United States National Library of Medicine in the clinical trials database (URL: <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"https://clinicaltrials.gov\">https://clinicaltrials.gov</jats:ext-link>; NCT03048045)","PeriodicalId":15380,"journal":{"name":"Journal of Clinical Periodontology","volume":"33 1","pages":""},"PeriodicalIF":5.8000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Periodontology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jcpe.14179","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
ObjectivesComparing periodontal stability following active periodontal treatment (APT/T1) and 120 ± 12 months of supportive periodontal care (SPC/T2) using four clinical endpoints (CEPs).MethodsCEP1: pocket probing depths (PPD) ≤ 4 mm, no sites with ≥ 4 mm with bleeding on probing (BOP), and total BOP < 10%; CEP2: no PPD > 4 mm with BOP or PPD ≥ 6 mm; CEP3: ≤ 4 sites with PPD ≥ 5 mm; CEP4: ≤ 5 teeth with PPD ≥ 5 mm. Assuming CEPs are mutually exclusive, patient‐ and tooth‐related parameters (e.g., periodontal tooth loss: PTL) were compared. Using receiver operating characteristic analysis for the prediction of PTL as a cutoff for CEP was assessed.ResultsFrom 128 patients (age 65.5 ± 10.5 years; 83 stage III, 45 stage IV; 47 grade B, 81 grade C), 7 achieved CEP1, 23 CEP2, 45 CEP3, 23 CEP4, 30 noCEP at T1. At T2, six patients reached CEP1, 37 CEP2, 38 CEP3, 35 CEP4, 12 noCEP. For noCEP, the number of sites with PPD > 5 mm increased significantly, and PTL was higher compared to CEP1, CEP2 and CEP3 (p < 0.001).ConclusionsWhile achieving CEP1 is possible through comprehensive APT, treating a chronic disease often leads to less ideal CEP2/CEP3. Achieving CEP1, CEP2 or CEP3 after APT made no observable difference regarding PTL.Trial Registration: The study is registered with the United States National Library of Medicine in the clinical trials database (URL: https://clinicaltrials.gov; NCT03048045)
期刊介绍:
Journal of Clinical Periodontology was founded by the British, Dutch, French, German, Scandinavian, and Swiss Societies of Periodontology.
The aim of the Journal of Clinical Periodontology is to provide the platform for exchange of scientific and clinical progress in the field of Periodontology and allied disciplines, and to do so at the highest possible level. The Journal also aims to facilitate the application of new scientific knowledge to the daily practice of the concerned disciplines and addresses both practicing clinicians and academics. The Journal is the official publication of the European Federation of Periodontology but wishes to retain its international scope.
The Journal publishes original contributions of high scientific merit in the fields of periodontology and implant dentistry. Its scope encompasses the physiology and pathology of the periodontium, the tissue integration of dental implants, the biology and the modulation of periodontal and alveolar bone healing and regeneration, diagnosis, epidemiology, prevention and therapy of periodontal disease, the clinical aspects of tooth replacement with dental implants, and the comprehensive rehabilitation of the periodontal patient. Review articles by experts on new developments in basic and applied periodontal science and associated dental disciplines, advances in periodontal or implant techniques and procedures, and case reports which illustrate important new information are also welcome.